Literature DB >> 3936768

Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphocytic leukaemia (CLL) in relation to disease activity.

E Kimby, H Mellstedt, M Björkholm, G Holm.   

Abstract

The surface membrane immunoglobulin (smIg) isotype pattern of the leukemic lymphocytes was studied in 66 unselected patients with CLL. Five distinct patient groups were identified according to the dominant heavy chain isotype(s); I: smmu + (n = 22), II: smmu +/smdelta + (n = 25), III: smdelta + (n = 4), IV: smgamma + (n = 5), V: no detectable heavy chains (n = 10). The majority of group I patients had a progressive disease at test while all patients in group II were in a non-progressive state. Moreover, the smIg pattern changed with the clinical activity of the disease: when the disease progressed, the relative number of smmu + cells increased and when patients entered an indolent stage after treatment the smmu + cell population decreased. In patients with stationary disease the smIg pattern remained essentially unchanged or the relative number of smdelta + cells increased. These observations might suggest that the smIg isotype pattern of the leukemic cell population reflects the biological behaviour and the clinical activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936768     DOI: 10.1002/hon.2900030405

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  3 in total

1.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.

Authors:  A Matolcsy; P Casali; R G Nádor; Y F Liu; D M Knowles
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

2.  Prognostic significance of immunoglobulin isotype expression in B-cell non-Hodgkin's lymphoma.

Authors:  C Lindemalm; B Christensson; G Biberfeld; P Biberfeld; M Björkholm; B Johansson; E Kimby; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

3.  Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Authors:  E Kimby; B Axelsson; M Björkholm; J Gordon; G Holm; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.